
Intensity Therapeutics
Innovative cancer treatments targeting both visible tumors and unseen micro metastases for extended patient survival.
Market cap
$13.7m
Enterprise value
$12m
Share price
$0.29 INTS
Authorizing premium user...
Innovative cancer treatments targeting both visible tumors and unseen micro metastases for extended patient survival.